Your product

Start with proven technical fit, then validate quality, maturity, capacity, and governance. Groupe PARIMA’s take: fit is not only equipment. It is the ability to execute your scope with consistent controls, clear communication, and predictable delivery once the program is in motion.

As a program advances, expectations around documentation, controls, and consistency become more demanding. Groupe PARIMA adapts the execution readiness to match the stage, so scale-up does not introduce avoidable surprises. Practically, this means tightening in-process controls, strengthening documentation, and ensuring the process can run repeatedly with predictable outcomes.

Because each dosage form responds differently to mixing, shear, hold times, and packaging, and those effects amplify at scale. Groupe PARIMA treats scale-up as more than a size increase. We focus on the specific failure modes that tend to appear by format, for example, stability risks in liquids, sedimentation and dose uniformity risks in suspensions, and rheology and consistency risks in semi-solids.

Confirm packaging strategy early, before finalizing the process and stability plan. Groupe PARIMA brings packaging considerations into the decision path early because container closure choices can affect stability and compatibility. Regulators expect appropriate container closure documentation and control.

Start with a proven fit for the dosage form, then confirm quality oversight, transfer readiness, and change control. Groupe PARIMA’s take is that “fit” is not only equipment or batch size. It includes how a CDMO runs the program: clear roles, clear documentation expectations, and a quality system that supports reliable execution and controlled changes over time.